Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes

Diabetes Care. 2021 Feb;44(2):e32-e34. doi: 10.2337/dc20-2080. Epub 2020 Dec 17.

Francesco Zaccardi^{1

2}, David E Kloecker^{3

2}, John B Buse⁴, Chantal Mathieu⁵, Kamlesh Khunti^{3

2}, Melanie J Davies^{2

6}

¹ Leicester Real World Evidence Unit, University of Leicester, Leicester, U.K. [email protected].
² Leicester Diabetes Centre, University of Leicester, Leicester, U.K.
³ Leicester Real World Evidence Unit, University of Leicester, Leicester, U.K.
⁴ Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC.
⁵ Clinical and Experimental Endocrinology, UZ Leuven campus Gasthuisberg, KU Leuven, Leuven, Belgium.
⁶ NIHR Leicester Biomedical Research Centre, Leicester General Hospital, Leicester, U.K.

No abstract available

Publication types